NRX Pharmaceuticals, Inc. (NRXP)
3.43
-0.24
(-6.54%)
USD |
NASDAQ |
Aug 26, 13:48
NRX Pharmaceuticals Total Assets (Quarterly) : 34.16M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 34.16M |
| March 31, 2026 | 11.90M |
| December 31, 2025 | 12.96M |
| September 30, 2025 | 15.00M |
| June 30, 2025 | 4.838M |
| March 31, 2025 | 7.59M |
| December 31, 2024 | 3.651M |
| September 30, 2024 | 4.462M |
| June 30, 2024 | 5.264M |
| March 31, 2024 | 3.788M |
| December 31, 2023 | 7.315M |
| September 30, 2023 | 13.11M |
| June 30, 2023 | 19.81M |
| March 31, 2023 | 21.78M |
| December 31, 2022 | 25.82M |
| September 30, 2022 | 24.82M |
| June 30, 2022 | 32.43M |
| March 31, 2022 | 43.60M |
| Date | Value |
|---|---|
| December 31, 2021 | 32.73M |
| September 30, 2021 | 45.25M |
| June 30, 2021 | 18.55M |
| March 31, 2021 | 6.028M |
| December 31, 2020 | 2.941M |
| September 30, 2020 | 6.032M |
| June 30, 2020 | 6.277M |
| March 31, 2020 | 6.273M |
| December 31, 2019 | 32.07M |
| September 30, 2019 | 41.69M |
| June 30, 2019 | 50.10M |
| March 31, 2019 | 71.71M |
| December 31, 2018 | 70.80M |
| September 30, 2018 | 69.89M |
| June 30, 2018 | 69.70M |
| March 31, 2018 | 69.55M |
| December 31, 2017 | 69.57M |
| September 30, 2017 | 0.1738M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 142.28B |
| Pfizer Inc. | 201.13B |
| Oramed Pharmaceuticals, Inc. | 369.64M |
| Yarrow Bioscience, Inc. | 23.60M |
| ANI Pharmaceuticals, Inc. | 1.494B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 34.33M |
| Shareholders Equity (Quarterly) | -0.17M |
| Debt to Equity Ratio | -7.329 |
| Current Ratio | 0.8608 |
| Net Debt Paydown Yield | 0.81% |